These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6989495)

  • 1. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration.
    Kimura NT; Taniguchi S; Aoki K; Baba T
    Cancer Res; 1980 Jun; 40(6):2061-8. PubMed ID: 6989495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.
    Yazawa K; Fujimori M; Amano J; Kano Y; Taniguchi S
    Cancer Gene Ther; 2000 Feb; 7(2):269-74. PubMed ID: 10770636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.
    Siems WG; Grune T; Schmidt H; Tikhonov YV; Pimenov AM
    Cancer Res; 1993 Nov; 53(21):5143-7. PubMed ID: 8221650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats.
    Sasaki T; Fujimori M; Hamaji Y; Hama Y; Ito K; Amano J; Taniguchi S
    Cancer Sci; 2006 Jul; 97(7):649-57. PubMed ID: 16827806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
    J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and tumor localization of effector cells in adoptive immunotherapy of cancer.
    Basse PH
    APMIS Suppl; 1995; 55():1-28. PubMed ID: 8534522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts.
    Eiseman JL; Lan J; Lagattuta TF; Hamburger DR; Joseph E; Covey JM; Egorin MJ
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):21-32. PubMed ID: 15338192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth.
    Li X; Fu GF; Fan YR; Liu WH; Liu XJ; Wang JJ; Xu GX
    Cancer Gene Ther; 2003 Feb; 10(2):105-11. PubMed ID: 12536198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
    Sinha AA; Quast BJ; Reddy PK; Elson MK; Wilson MJ
    Anticancer Res; 1999; 19(2A):893-902. PubMed ID: 10368631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
    JĂșnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
    Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of yoghurt and soya yoghurt containing bifidobacteria on the proliferation of Ehrlich ascites tumour cells in vitro and in vivo in a mouse tumour model.
    Abd el-Gawad IA; el-Sayed EM; Hafez SA; el-Zeini HM; Saleh FA
    Br J Nutr; 2004 Jul; 92(1):81-6. PubMed ID: 15230990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes].
    Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
    Kozin SV; Kozina LV
    Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
    Horak E; Hartmann F; Garmestani K; Wu C; Brechbiel M; Gansow OA; Landolfi NF; Waldmann TA
    J Nucl Med; 1997 Dec; 38(12):1944-50. PubMed ID: 9430475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
    Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
    Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors.
    Zhu LP; Yin Y; Xing J; Li C; Kou L; Hu B; Wu ZW; Wang JJ; Xu GX
    Cancer Sci; 2009 Oct; 100(10):1986-90. PubMed ID: 19678823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.